Abstract:Objective Infection with clarithromycin-resistant Helicobacter pylori (Hp) is often predictive of treatment failure. Susceptibility testing for Hp could guide therapy of Hp infections. However, agar dilution approved by the Clinical and Laboratory Standards Institute (CLSI) to test for antimicrobial susceptibility of Hp is time consuming (results are often not available in a week or more). So a more expeditious method is necessary. The purpose of this study was to evaluate pelymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) test performed directly on gastric biopsy specimen from children to detect 23S rRNA mutations (A2143G and A2144G) indicating clarithromycin resistance. Methods All biopsy specimens were derived from patients presenting with upper gastrointestinal symptoms, submitted to endoscopy in the Affiliated Children's Hospital, Zhejiang University School of Medicine from September 2006 to February 2007. No patients had undergone eradication therapy. Thirty-nine samples ramdonly selected from positive specimens by rapid urease test, were homogenized in 500 μl brucella broth with 30% glycerol. The 200 μl homogenized fluid was used to purify genomic DNA with the kit according to the instructions provided by manufacturer, and the rest was used to isolate Hp strains by culturing. All the Hp isolates were tested for clarithromycin susceptibility with the agar dilution and classified as resistant if the minimum inhibitory concentrations (MIC) exceeded 1 μg/ml. Simultaneously, PCR-RFLP analysis was performed in order to identify 23S rRNA mutations (A2143G and A2144G). Finally, the two methods were compared by statistics. The agar dilution was used as a standard to dertermine the sensitivity and specificity of the PCR-RFLP assay. Results Of the 39 samples, agar dilution and PCR-RFLP method respectively detected 13 (33.3%) and 14 (35.9%) clarithromycin-resistant gastric specimens. The sensitivity and specificity of PCR-RFLP for the detection of Hp in biopsy specimens were both 92%. The positive and negative predictive value was 85.7% and 96% respectively. No statistically significant difference was found between the two methods (x~2=0.06, P > 0.05). The rate of Hp resistance to clarithromycin significantly increased compared with a previous report from the authors' hospital in 2004 (x~2=6.20, P < 0.05). Conclusions Rising clarithromycin resistance rates were observed in children who visited the authors' hospital. PCR-RFLP test is reliable and rapid for detection of clarithromycin resistance directly on gastric biopsy specimen from children and may help choose appropriate antibiotic in Hp eradication therapy.

Molecular Testing for H. Pylori Clarithromycin and Quinolone Resistance: a Prospective Chinese Study

Evaluation of Multiplex ARMS-PCR for Detection Ofhelicobacter Pylorimutations Conferring Resistance to Clarithromycin and Levofloxacin

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for <i>Helicobacter pylori</i> infection: a protocol of a single-centre, single-blind, randomised clinical trial in China

Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin

Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real‐time PCR

Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China.

Oligonucleotide Microarray: A New Rapid Method for Screening the 23S Rrna Gene of Helicobacter Pylori for Single Nucleotide Polymorphisms Associated with Clarithromycin Resistance

Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter Pylori Strains from Children in China

Feasibility of Amplification Refractory Mutation System in Fast Detection of Clarithromycin Resistance of Helicobacter Pylori in Gastric Mucosa

Genotype profiles of Helicobacter pylori from gastric biopsies and strains with antimicrobial-induced resistance.

Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy

Genotype profiles of from gastric biopsies and strains with antimicrobial-induced resistance

Antibiotic Resistance of Helicobacter Pylori in Chinese Children: A Multicenter Study from 2016 to 2023.

Evaluation of a Molecular Mosprie Assay for Detection of Helicobacter pylori and Resistance to Clarithromycin and Levofloxacin.

Direct Detection of Antibiotic Resistance in Chinese Helicobacter pylori Clinical Isolates by Sequencing-Based Approach

Rapid detection of clarithromycin resistant Helicobacter pylori from children's gastric biopsy specimens by ploymerase chain reaction-restriction fragment length polymophism

Screening of Single Nucleotide Polymorphism of a 23S Rrna Gene from Helicobacter Pylori Associated with Clarithromycin Resistance Using Oligonucleotide Microarray

Microarray-Based Detection and Clinical Evaluation for Helicobacter pylori Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 Patients

Employment of TaqMan-MGB fluorescent probe real-time PCR for detection of the quinolones resistant mutations of Helicobacter pylori in Beijing area

Multiplex PCR-ASE functionalized microfluidic diagnostic platform for the detection of clarithromycin resistance mutations in Helicobacter pylori

Prospective Multi-Region Study on Primary Antibiotic Resistance of Helicobacter Pylori Strains Isolated from Chinese Patients